Deucrictibant extended-release tablet

deucrictibant · Pharvaris Netherlands B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Deucrictibant extended-release tablet, covering 2026-02-13 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE [Phase 3]

See pricing